A bottle of poison pills casts a shadow over a map of the U.S.

Today The Partnership for Safe Medicines filed comments with Health and Human Services about the dangers posed by its draft regulations for state-based Canadian drug importation programs. PSM cited historic problems with and patient harm from Canadian vendors selling counterfeit medications to U.S. patients and medical practices; showed broad opposition to the plan by Canadian stakeholders; and provides alternatives that don’t impact patient safety.

[...]

Partnership for Safe Medicines Statement on Proposed Regulations to Import Prescription Medicines from Canada Washington, D.C. (December 18, 2019) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to today’s announcement by the Trump Administration and the proposed regulations to allow importation of prescription medicines: “Citizens of…

[...]